Newsroom

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of QVC, Inc. (the “Company”) from the Exchange. Trading in the Company’s Securities will be suspended immediately. Symbol Description QVCC 6.250% Senior Secured Notes due 2068 QVCD 6.375% Senior Secured Notes due 2067 NYSE Regulation reached its decision that the Compa...

INDIANAPOLIS--(BUSINESS WIRE)--hc1®, the leader in agentic lab data intelligence for healthcare, today announced that its Founder, Chairman, and CEO, Bradley Bostic, has been named to the prestigious Crain's Chicago Business Notable Leaders in Health Care 2026 list. This recognition highlights Bostic's commitment to advancing healthcare delivery by utilizing AI-driven insights to maximize cost savings, reduce waste, and drive operational efficiency across comprehensive health systems. Under Bos...

BOSTON--(BUSINESS WIRE)--Eaton Vance Limited Duration Income Fund (NYSE: EVV), Eaton Vance Senior Floating-Rate Trust (NYSE: EFR), and Eaton Vance Senior Income Trust (NYSE: EVF) (each a “Fund,” and together, the “Funds”) announced that the Board of Trustees of each Fund has authorized each Fund to conduct a voluntary tender offer for up to 100% of its outstanding auction preferred shares (“APS”) at a price per share equal to 98% of the APS liquidation preference of $25,000 per share (or $24,50...

CANTON, Massachusetts--(BUSINESS WIRE)--Orthogon Therapeutics a annoncé aujourd’hui la clôture d’un tour de table de 11 millions de dollars, portant le montant total des fonds levés par l’entreprise à 36 millions de dollars. Ce financement permettra à l’entreprise de poursuivre le développement de son médicament innovant contre le polyomavirus BK. Les infections par ce virus constituent une cause majeure de complications chez les patients ayant reçu une greffe d’organe, et aucun traitement n’es...

BOSTON--(BUSINESS WIRE)--MassEcon honors Avangrid for growing the Massachusetts economy and strengthening the Commonwealth’s ability to compete in the global economy...

CANTON, Massachusetts--(BUSINESS WIRE)--Orthogon Therapeutics gab heute den Abschluss einer Folgefinanzierung in Höhe von 11 Millionen US-Dollar bekannt, womit sich das insgesamt eingeworbene Kapital auf 36 Millionen US-Dollar erhöht. Die Finanzierung ermöglicht die weitere Entwicklung des First-in-Class-Medikaments gegen das BK-Polyomavirus. BK-Virus-Infektionen sind eine der Hauptursachen für Komplikationen bei Transplantationspatienten, wobei es bislang keine zugelassenen Behandlungsmethoden...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Green Circle Decarbonize Technology Ltd. (NYSE American: GCDT) resulting from allegations that Green Circle may have issued materially misleading business information to the investing public. So what: If you purchased Green Circle securities you may be entitled to compensation without payment of any out of pocket fees or costs...

CANTON, Massachusetts--(BUSINESS WIRE)--A empresa anunciou hoje o fechamento de um financiamento adicional de US$ 11 milhões, elevando o capital total levantado para US$ 36 milhões. Esse investimento apoiará o avanço contínuo de seu medicamento pioneiro contra o poliomavírus BK. As infecções pelo BK são uma das principais causas de complicações em pacientes transplantados, e não há tratamentos aprovados para elas. A empresa é pioneira em uma terapia oral que abrange todo o espectro da infecção...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Studies will showcase the ultrasensitive structural variant-based detection of ctDNA in metastatic breast cancer and high-grade serous ovarian cancer...

SAN DIEGO--(BUSINESS WIRE)--Qualcomm Incorporated (NASDAQ: QCOM) ha anunciado hoy un dividendo trimestral en efectivo de 0,92 dólares por acción ordinaria, pagadero el día 25 de junio de 2026 a los accionistas registrados al cierre de la jornada del 4 de junio de 2026. Acerca de Qualcomm Qualcomm innova sin descanso para que la informática inteligente llegue a todas partes y sea una herramienta para que el mundo a abordar algunos de sus desafíos más importantes. Con el aval de 4 décadas de lide...